Cargando…
Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19
COVID-19 caused by the novel SARS-CoV-2 has been declared a pandemic by the WHO is causing havoc across the entire world. As of May end, about 6 million people have been affected, and 367 166 have died from COVID-19. Recent studies suggest that the SARS-CoV-2 genome shares about 80% similarity with...
Autores principales: | Faheem, Kumar, Banoth Karan, Sekhar, Kondapalli Venkata Gowri Chandra, Kunjiappan, Selvaraj, Jamalis, Joazaizulfazli, Balaña-Fouce, Rafael, Tekwani, Babu L., Sankaranarayanan, Murugesan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476961/ https://www.ncbi.nlm.nih.gov/pubmed/32947136 http://dx.doi.org/10.1016/j.bioorg.2020.104269 |
Ejemplares similares
-
Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs – biological activities and SAR studies
por: Faheem,, et al.
Publicado: (2021) -
Recent evolution on synthesis strategies and anti-leishmanial activity of β-carboline derivatives – An update
por: Banoth, Karan Kumar, et al.
Publicado: (2020) -
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
por: Nandikolla, Adinarayana, et al.
Publicado: (2020) -
Design, synthesis and biological evaluation of benzo-[d]-imidazo-[2,1-b]-thiazole and imidazo-[2,1-b]-thiazole carboxamide triazole derivatives as antimycobacterial agents
por: Chitti, Surendar, et al.
Publicado: (2022) -
l-Ornithine-N5-monooxygenase (PvdA) Substrate Analogue Inhibitors for Pseudomonas aeruginosa Infections Treatment: Drug Repurposing Computational Studies
por: Rosy, Joseph Christina, et al.
Publicado: (2022)